Skip to main content
Clinical Trials/ISRCTN14489433
ISRCTN14489433
Active, not recruiting
未知

Developing and evaluating a mobile phone-based early alert system using high-resolution air quality forecast to improve asthma control in Malaysia

Accord (United Kingdom)0 sites60 target enrollmentAugust 1, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Improving asthma control among adult patients with asthma during increased outdoor pollution.
Sponsor
Accord (United Kingdom)
Enrollment
60
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2023
End Date
June 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Accord (United Kingdom)

Eligibility Criteria

Inclusion Criteria

  • 1\. Adult patients aged 18 years old and above with physician\-diagnosed asthma and receiving asthma treatment in the previous year
  • 2\. Adult patients who live in Klang District for the duration of the study
  • 3\. Patients who had reported poor asthma control and exacerbation aggravated by haze (findings from baseline study in RESPIRE 1\)
  • 4\. Patients who are on controller medication (e.g., an inhaled corticosteroid (ICS), inhaled combination ICS/long\-acting beta\-agonists (LABA), leukotriene receptor antagonist (LTRA))
  • 5\. Patients who own and are able to use a smartphone
  • 6\. Patients who are able to understand the Malay/English language
  • 7\. Patients who are willing and able to give consent to participate in the study

Exclusion Criteria

  • 1\. Patients below 18 years of age
  • 2\. Patients who have respiratory symptoms (e.g., cough, breathlessness, wheezing) due to other conditions for example established physician diagnoses of:
  • 2\.1\. Respiratory infection e.g., pneumonia, tuberculosis (but not having underlying asthma)
  • 2\.2\. Chronic obstructive pulmonary diseases
  • 2\.3\. Congenital heart disease
  • 2\.4\. Heart, liver or renal failure
  • 2\.5\. Gastro\-esophageal reflux
  • 2\.6\. Active life\-threatening malignancy and those receiving palliative care
  • 3\. Patients who have disabilities (physical/psychological) that may interfere with the completion of the study
  • 4\. Patients who are unwilling or unable to provide written informed consent (e.g. cognitive impairment)

Outcomes

Primary Outcomes

Not specified

Similar Trials